Abstract
Panic disorder (PD) is an anxiety disorder that is highly disruptive to the patient’s life and needs new options for effective treatments. In this case report, we present an application of repetitive transcranial magnetic stimulation (rTMS) in a refractory patient resistant to cognitive behavior therapy (CBT) and pharmacotherapy who was treated with a combined protocol of rTMS with a sequential stimulation of right and left dorsolateral prefrontal cortex (DLPFC). The protocol was conducted 3 times per week during 4 weeks, with one month follow-up. The fact that the patient showed improvement suggests that rTMS can be an effective option of treatment.
Keywords: Dorsolateral prefrontal cortex, panic disorder, repetitive transcranial magnetic stimulation, rTMS.
CNS & Neurological Disorders - Drug Targets
Title:Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Refractory Panic Disorder Patient: A Case Report
Volume: 13 Issue: 6
Author(s): Sergio Machado, Veruska Santos, Flavia Paes, Oscar Arias-Carrion, Mauro G. Carta, Adriana C. Silva and Antonio E. Nardi
Affiliation:
Keywords: Dorsolateral prefrontal cortex, panic disorder, repetitive transcranial magnetic stimulation, rTMS.
Abstract: Panic disorder (PD) is an anxiety disorder that is highly disruptive to the patient’s life and needs new options for effective treatments. In this case report, we present an application of repetitive transcranial magnetic stimulation (rTMS) in a refractory patient resistant to cognitive behavior therapy (CBT) and pharmacotherapy who was treated with a combined protocol of rTMS with a sequential stimulation of right and left dorsolateral prefrontal cortex (DLPFC). The protocol was conducted 3 times per week during 4 weeks, with one month follow-up. The fact that the patient showed improvement suggests that rTMS can be an effective option of treatment.
Export Options
About this article
Cite this article as:
Machado Sergio, Santos Veruska, Paes Flavia, Arias-Carrion Oscar, Carta G. Mauro, Silva C. Adriana and Nardi E. Antonio, Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Refractory Panic Disorder Patient: A Case Report, CNS & Neurological Disorders - Drug Targets 2014; 13 (6) . https://dx.doi.org/10.2174/1871527313666140612112148
DOI https://dx.doi.org/10.2174/1871527313666140612112148 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Extract of <i>Moringa concanensis</i> Nimmo Leaves Ameliorates Hyperglycemia and Oxidative Stress, and Improves β-cell Function in Alloxan Monohydrate Induced Diabetic Rats
Current Bioactive Compounds Theory and Application of Microdialysis in Pharmacokinetic Studies
Current Drug Metabolism Non-Antidepressant Pharmacologic Long-Term Treatment of Panic Disorder
Current Clinical Pharmacology Transglutaminases - Possible Drug Targets in Human Diseases
Current Drug Targets - CNS & Neurological Disorders From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
CNS & Neurological Disorders - Drug Targets Preface
Current Medical Imaging Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats
Current Neurovascular Research Prevalence, Severity and Characteristics of Tardive Dyskinesia Among Schizophrenia Patients in an Israeli Psychiatric Center
Current Psychopharmacology Brain Tumor-Related Epilepsy
Current Neuropharmacology Glycoconjugates: Roles in Neural Diseases Caused by Exogenous Pathogens
CNS & Neurological Disorders - Drug Targets Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Current Clinical Pharmacology ABC Transporters in Extrahepatic Tissues: Pharmacological Regulation in Heart and Intestine
Current Medicinal Chemistry Teratogenic Activity of HDAC Inhibitors
Current Pharmaceutical Design Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology Antiepileptic Drugs in the Neurosurgical Intensive Care
Current Pharmaceutical Design Inhibitors of Mammalian Central Nervous System Selective Amino Acid Transporters
Current Medicinal Chemistry Use of Antiepileptic Drugs for Hyperkinetic Movement Disorders
Current Neuropharmacology Antipsychotic Medication Adherence and Satisfaction Among Palestinian People with Schizophrenia
Current Clinical Pharmacology Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued)